Base Year
Historical Year
Forecast Year
The actinic keratosis treatment market size attained a value of USD 7.40 billion in 2023 driven by environmental factors such as the depletion of ozone and prolonged sun exposure environmental factors such as the depletion of ozone and prolonged sun exposure. The market is anticipated to grow at a CAGR of 4.2% during the forecast period of 2024-2032 to attain a value of USD 10.71 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The increased prevalence of actinic keratosis, driven by environmental factors such as the depletion of ozone and prolonged sun exposure, is the major factor driving the growth of the actinic keratosis treatment industry globally.
Actinic keratosis refers to the growth of scaly patch on skin that grows out of years of sun exposure. Chances of its occurrence are more in people who are exposed to sunlight, and, thus, are at higher risk of actinic keratosis. The growth of actinic keratosis could lead to squamous cell carcinoma, which is a type of cancer.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global actinic keratosis treatment industry can be broadly categorised based on segments like therapy, drug class, end-uses, and regions.
The EMR report looks into the regional actinic keratosis treatment markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific
It is projected that the increasing prevalence of actinic keratosis, the rising acceptance of minimally invasive therapeutic procedures, the availability of appropriate medical coverage, and a growing geriatric population are the major drivers of the market growth. However, the risk factors associated with available treatment options may hamper industry growth over the forecast period.
The hospitals segment, among other end uses, dominates the industry owing to the ease of accessibility, rise in healthcare infrastructure, and the growing number of patients.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The report presents a detailed analysis of the following key players in the global actinic keratosis treatment market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Treatment Type |
|
| Breakup by End User |
|
| Breakup by Treatment Channel |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
In 2023, the global market for actinic keratosis reached a value of USD 7.40 billion.
The market is anticipated to grow at a CAGR of 4.2% during the forecast period of 2024-2032 to reach a value of USD 10.71 billion by 2032.
The major drivers of the market include the increasing prevalence of actinic keratosis, growing acceptance of minimally invasive therapeutic procedures, and increasing geriatric population.
Depletion of ozone layer leading to an increased incidence of actinic keratosis is the key industry trend propelling the growth of the market.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading therapies of actinic keratosis treatment in the market are topical, surgery, and photodynamic therapy.
The major drug classes of actinic keratosis treatment in the industry are nucleoside metabolic inhibitors, nonsteroidal anti-inflammatory drugs, immune response modifiers, and photoenhancers, among others.
The significant end use sectors of actinic keratosis treatment in the market are hospitals, private clinics, and homecare, among others.
The major players in the industry are Bausch Health Companies Inc., LEO Pharma A/S, Almirall, S.A., Biofrontera, and Hill Dermaceuticals Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share